Gabrielle Alison Silver, Director at OPIANT PHARMACEUTICALS, INC. (OPNT), sold 20,163 shares at $11.07 ($226K) on 2021-03-17, disclosed to the SEC on 2021-03-17.
Open-market sale of $226k OPNT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.64 | 3,900 | $45K | 20.1% |
| 2 | $11.50 | 1,949 | $22K | 9.9% |
| 3 | $11.07 | 7,157 | $79K | 35.0% |
| 4 | $11.07 | 7,157 | $79K | 35.0% |
| Total | $11.22 avg | 20,163 | $226K | 100% |
| Filing → |
| OPNT | BUY | 2019-11-25 | $24K | — | Filing → |